“We are thrilled about our new partnership with Insignia. We expect its strategic and operational expertise to be immensely valuable as we seek to accelerate our growth,” said Chris Wiltshire, President, MNG Direct™.
(PRWEB) September 08, 2015
Pharmaceutical marketing group metanexgen announced today it is changing its corporate identity to MNG Direct™. Recently acquired by Insignia Capital Group, MNG Direct™ provides technology-enabled multichannel marketing solutions for brands to cost effectively connect with health care providers.
Unveiled this month, the rebrand debuts a new company logo, user-friendly website, and simplified product navigation to enable clients to shape their success.
“We are thrilled about our new partnership with Insignia. We expect its strategic and operational expertise to be immensely valuable as we seek to accelerate our growth,” said Chris Wiltshire, President, MNG Direct™. “We have built a diverse, multichannel marketing solution set to serve our clients’ growing needs. With the help of Insignia, we intend to further develop and integrate our offerings to deliver a true multichannel solution that provides significant ROI to our clients.”
MNG Direct™ now offers marketing teams:
- 100% target HCP reach
o 90% reach via email and 10% reach via direct mail
- Multichannel HCP engagement solutions
o Direct Mail
o Email Marketing
o Video Marketing
o Virtual Engagements
o Marketing Automation
- Speed to market
o Delivery as fast as 1-6 weeks
- Highly experienced team
o ~30,000 unique medical/legal/regulatory approved marketing pieces developed and deployed
- Robust information technology infrastructure
o Highest industry certification levels for data compliance, security, availability, and scalability
- Very satisfied clients
o 96% would recommend MNG Direct™ to a colleague
The MNG Direct™ transformation began in early 2013 when online video and virtual meeting provider NexGen RxMarketing merged with data-driven email and direct mail agency Meta Pharmaceutical Services to form metanexgen. With the added resources of Insignia Capital Group, MNG Direct™ now provides a full, multichannel marketing suite for pharmaceutical, biotechnology, and medical device brands.
“We believe full-service offerings and technology solutions positon MNG Direct at the forefront of the multichannel marketing sector,” said Tony Broglio, a Partner at Insignia. “We look forward to supporting management to further build upon the Company’s market position with the goal of producing a successful and rewarding outcome for clients, employees, and shareholders.”
About MNG Direct™
Based in Bensalem, PA, MNG Direct™ builds data-driven multichannel marketing solutions that provide 100% target HCP reach and the highest engagement rates in the industry for pharmaceutical, biotechnology, and medical device brands. For more information on MNG Direct™, visit us at http://www.mngdirect.com or find us on Twitter at http://www.Twitter.com/MNGDirect.
About Insignia Capital Group
Insignia Capital Group is a private equity firm based in the San Francisco Bay Area, focused on investing in lower middle-market businesses where it can partner with leading management teams to achieve their true business potential. The firm’s principals have significant experience building businesses across a range of industries including healthcare, business services, and consumer. For more information please visit http://www.insigniacap.com.